In May 2015, the 21st Century Cures Act was introduced in the U.S. House of Representatives, with the goal of promoting the development and speeding the approval of new drugs and devices.1 Championed by the pharmaceutical, biotechnology, and device industries, the bill was approved unanimously (51 to 0) in committee and continues to be debated. If enacted into law, some of its provisions could have a profound effect on what is known about the safety and efficacy of medical products, as well as which ones become available for use. (Perspective)
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/21st-century-cures-act-%E2%80%94-will-it-take-us-back-time
[2] http://admin.indiaenvironmentportal.org.in/category/author/jerry-avorn
[3] http://admin.indiaenvironmentportal.org.in/category/author/aaron-s-kesselheim
[4] http://admin.indiaenvironmentportal.org.in/category/journal/new-england-journal-medicine
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/united-states-america-us
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-policy
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/legislation
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
